SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-17
👔
Korro Bio, Inc.
@KRRO_InsiderForm 4 Filing: Dolan Oliver Acquires (Grant) shares of $KRRO
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Korro Bio, Inc.
Ticker: $KRRO
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-15
Shares: 5,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Dolan Oliver, holds the title of Senior Vice President, Finance at Korro Bio, Inc..
On 2026-07-15, the insider transacted 5,500 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Dolan Oliver (Senior Vice President, Finance) was granted $0 of $KRRO
Post-Transaction Position: 23,599 shares
SEC Accession No: 0001193125-26-306742 (CIK: 2053835)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.